news
Rare mutations in 36 genes link OCD and tic disorders
A genetic study of nearly 4,000 patients identified damaging mutations across 36 genes that drive risk for both OCD and Tourette or tic syndromes. Most of the variants were shared between conditions, pointing directly to disrupted synaptic signaling and basal ganglia function. The findings show both disorders share the same cellular origin.
A genetic study of nearly 4,000 patients identified damaging mutations across 36 genes that drive risk for both OCD and Tourette or tic syndromes. Most of the variants were shared between conditions, pointing directly to disrupted synaptic signaling and basal ganglia function. The findings show both disorders share the same cellular origin.
The architecture take
I spent years watching clinicians treat OCD purely as obsessive worry and tics as an unrelated motor hiccup. This massive 4,000-person genetic screen completely scrambles that separation. When 36 rare gene mutations show up across both conditions, the line between an intrusive thought and an involuntary twitch disappears at the cellular level. Both trace back to how neurons fire across the basal ganglia, relying on identical dopamine and synaptic pathways. For anyone caught in chronic loops, this changes the clinical playbook. It moves the conversation away from coping drills and plants the issue in cellular wiring. I suspect drug development will follow this pivot fast. Instead of blunting emotional range with broad SSRIs, biotech pipelines will target specific synaptic ion channels and basal ganglia signaling. Watch for combined trials treating both syndromes under one molecular banner by next year.